← All trials
NCT05096312
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 21, 2018
- Primary completion
- Jul 19, 2019
- Completion date
- Jul 20, 2019
- First posted
- Oct 27, 2021
- Last posted
- Oct 27, 2021
- Enrollment
- 23
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- East Avenue Medical Center, PhilippinesLead sponsor
- East Avenue Medical Center, PhilippinesReponsible party - principal investigator
- East Avenue Medical Center, PhilippinesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.